IMS Health acquires HGS Europe

IMS Health brought market access firm HGS Europe into the fold last month.

The UK company, which was founded in 1998 by Angela and Graeme McFarland, has expertise in understanding the market access piece of a launch as well as what cost-effectiveness ­gatekeepers such as NICE are looking for.

Mike Sanvoisin, the GM of UK and Ireland for IMS, told MM&M that IMS will be looking to link its own real-world data assets with HGS's strategies in order to help European payers see how drugs are performing in the real world. “Payers want to see that investments they make are having an effect,” Sanvoisi said. “That's where we see the synergy of HGS coming in.”

You must be a registered member of MMM to post a comment.

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.